Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: New anti-tumor strategy based on acid-triggered self-destructive and near-infrared laser light responses of nano-biocatalysts integrating starvation–chemo–photothermal therapies

Fig. 6

Investigation of cellular abnormalities and intracellular catalytic mechanism. The concentration of PEG-MoS2, or M@D/G@M used below is 50 µg mL−1. A The relative percentage of intracellular GSH and B MDA content. C Linear relationship between different concentrations of MDA standards and the absorbance measured by the microplate reader. (n = 3, **p < 0.01). D Generation of ROS after being treated with PBS (a), H2O2 (b), PEG-MoS2 (c), and M@D/G@M (d). Scale bar: 50 μm. E Apoptosis analyses of HepG2 cells upon 24 h exposure to PBS; PEG-MoS2, M@D/G@M, M@D/G@M + pH6.0 + NIR groups, respectively

Back to article page